... Rystad Energy, by the end of 2024, 17.8 million tons of LNG were delivered as well. Ekaterina Kosareva noted that the main buyers of Russian oil today are China and India, which absorb the vast majority of this resource. “All consequences from the loss of the European market were already played out by Russia and particularly by Gazprom following the 2023 financial report. At that point, Russia was able to quickly redirect its hydrocarbon export flows to other markets,” Natalia Milchakova recalled....

... will be able to operate legally and compete with banks, offering investors more diverse products and sources of income. However, a liberal approach also carries risks: overly lenient oversight may lead to hacking, "pyramid" schemes, and mass losses due to code vulnerabilities; excessively strict regulations, on the other hand, may push innovation into the shadows or abroad. Authorities must find a balance between promoting DeFi and protecting users to ensure that this sector develops sustainably ...

... This approach allows a single mirror to be used more effectively, maintaining generation at optimal levels from morning till evening. Furthermore, both towers operate simultaneously on a single turbine, simplifying infrastructure and reducing energy losses. Developers estimate that this solution enhances the solar energy utilization factor by about 24% compared to traditional single-tower architectures. The high efficiency of the installation is further facilitated by the quality of the heliostats: ...

... framework. Risks for the Industry and Society The plans for legislative revision have alarmed the nascent legal cannabis industry. Companies that invested in the cultivation and sale of marijuana through social clubs or pharmaceutical channels fear losses. If new restrictions are imposed, some consumers will inevitably return to illegal suppliers, which will hurt officially registered producers. Moreover, tightening the rules may complicate life for patients who genuinely need cannabis for medical ...

... supply. Pharmaceuticals and Biotech: Biotechnology firm Moderna and pharmaceutical company Regeneron Pharmaceuticals will publish their reports. Moderna, experiencing a sharp decline in revenue following a boom in vaccine demand, is likely to report a loss for the quarter. Conversely, Regeneron is expected to show stable income thanks to sales of its flagship drugs. Industry and Raw Materials: In this segment, results will be released by chemical and technology conglomerate LyondellBasell, industrial ...